Pep2Tango Therapeutics
Pep2Tango Therapeutics is a startup headquartered in Potomac, United States, founded in 2021. It has raised at least $16.7m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Pep2Tango Therapeutics has raised at least $16.7m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Pep2Tango Therapeutics sits inside the Washington DC and Maryland R&D ecosystem in the Global R&D Labs Directory.
Related
- Innovation profile of Potomac
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Pep2Tango Therapeutics do?
Pep2Tango Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Pep2Tango Therapeutics raised?
At least $16.7m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Pep2Tango Therapeutics based?
Pep2Tango Therapeutics is headquartered in Potomac, United States.
When was Pep2Tango Therapeutics founded?
Pep2Tango Therapeutics was founded in 2021.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.